Annette von Drygalski

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht et al. · New England Journal of Medicine · 2023 · 343 citations · Full text

Medicine, Hematology, Molecular Medicine +16

Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis

Matthew S. Macauley, Fabian Pfrengle, Christoph Rademacher et al. · Journal of Clinical Investigation · 2013 · 232 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Vancomycin-Induced Immune Thrombocytopenia

Annette von Drygalski, Brian R. Curtis, Daniel W. Bougie et al. · New England Journal of Medicine · 2007 · 222 citations · Full text

Medicine, Hematology, Pharmacology +10

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

Johnny Mahlangu, Radosław Kaczmarek, Annette von Drygalski et al. · New England Journal of Medicine · 2023 · 191 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Barbara A. Konkle, Christopher Walsh, Miguel A. Escobar et al. · Blood · 2020 · 188 citations · Full text

Life Sciences, Hematology, Molecular Biology +5